Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 Study Designed to Support Planned...
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients and Address Public Health Crisis...
Greenville, South Carolina, Aug. 14, 2023 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based...
VANCOUVER, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"),...
Responding to the growing need for detoxification services and acute mental health stabilization, Lifeskills added a campus in Ft. Lauderdale.BRENTWOOD,...
On track to present initial data from Phase 1/2 clinical trial of MRT-2359 for MYC-driven solid tumors in the second...
SBS-518 is a dual sigma receptor antagonist/dopamine active transporter inhibitor in development for the treatment of stimulant use disorder (e.g.,...
Topline Results Expected Third Quarter 2023 Long COVID Afflicts Approximately 19% of Patients Following COVID-191, and is Expected to be...
Common Stock Will Begin Trading on Split-Adjusted Basis on August 7, 2023CHARLOTTESVILLE, Va., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adial...
HOUSTON--(BUSINESS WIRE)--Lightning Step today announced the appointment of Fred Sheffield as its Chief Revenue Officer (CRO). With a track record...
LONDON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The Trip Report by Beckley Waves, a leading publication on the business, science,...
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that...
Mental health and sobriety platform launches to provide sobriety resources to those facing challenges with their drinking PHILADELPHIA, Aug. 2,...
Calgary, Alberta--(Newsfile Corp. - August 1, 2023) - The Newly Institute Inc. ("Newly" or the "Company") wishes to announce that,...
Vancouver, British Columbia--(Newsfile Corp. - August 1, 2023) - Safe Supply Streaming Co. Ltd. ("Safe Supply" or "SSSC" or "the...
Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
-A Phase 2a study of BAER-101 in epilepsy is planned to initiate in 2024MIAMI, Aug. 01, 2023 (GLOBE NEWSWIRE) --...
Sale Completes Awakn's Exit From Healthcare Services To Focus Solely on Biotechnology Research and DevelopmentToronto, Ontario--(Newsfile Corp. - August 1,...
This announcement contains inside informationStrategic Divestment of C4XD's Orexin-1 Receptor Antagonist Programme to Indivior for £15.95 MillionSale encompasses all rights...
OKYO plans a 40-patient OK-101 open-label clinical trial with Dr Pedram Hamrah, Tufts Medical Center, as Principal Investigator, a leading...